EDGAR Filing Documents for 0000950135-96-004074

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0000950135-96-004074

Filing Date

1996-09-24

Accepted

1996-09-24 00:00:00

Documents

SROs

NASD

Document Format Files

Seq	Description	Document	Type	Size
1	NEOZYME II & GENZYME CORP. SCHEDULE 13D/A		SC 13D/A	10298
2	PURCHASE AGREEMENT		EX-99.A	95163
3	PRESS RELEASE DATED 9/23/96		EX-99.B	4248
	Complete submission text file	0000950135-96-004074.txt		111873

Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139

Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500

GENZYME CORP (Filed by) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE KENDALL SQUARE BRIDGE MA 02139

Business Address TODMAN BLDG MAIN ST ROAD TOWN TORTOLA BRITISH VIRG D8 8094942065

NEOZYME II CORP (Subject) CIK: 0000884392 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42416 | Film No.: 96633954
SIC: 2836 Biological Products, (No Diagnostic Substances)